Provided by Tiger Fintech (Singapore) Pte. Ltd.

Super League Gaming Inc.

0.3717
+0.01072.96%
Post-market: 0.41490.0432+11.62%19:57 EDT
Volume:158.77K
Turnover:58.79K
Market Cap:6.17M
PE:-0.08
High:0.3855
Open:0.3700
Low:0.3610
Close:0.3610
Loading ...

This Super League Enterprise Insider Increased Their Holding By 46% Last Year

Simply Wall St.
·
20 Feb

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

GlobeNewswire
·
13 Feb

Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update

GlobeNewswire
·
13 Feb

Royalty Pharma Announces R&D Funding Collaboration With Biogen

GlobeNewswire
·
12 Feb

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
12 Feb

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement

Business Wire
·
05 Feb

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

GlobeNewswire
·
05 Feb

Strength Seen in Exagen (XGN): Can Its 29.4% Jump Turn into More Strength?

Zacks
·
05 Feb

Jail, caning for teen in SLE bike chase that killed LTA officer

CNA
·
23 Jan

RedHill's Talicia® Adds 8 Million Lives With Coverage by Humana®'s Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published

PR Newswire
·
21 Jan

Press Release: Autolus Therapeutics Provides Business Updates and 2025 Overview

Dow Jones
·
13 Jan

Autolus Therapeutics Provides Business Updates and 2025 Overview

GlobeNewswire
·
13 Jan

Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025

GlobeNewswire
·
13 Jan

Press Release: Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results

Dow Jones
·
13 Jan

Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones

Business Wire
·
09 Jan

GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds

GlobeNewswire
·
23 Dec 2024